Fig. 7. Content of cyclic guanosine 3′,5′-monophosphate (cGMP) in the dorsal half of the lumbar spinal cord. Control = perfusion of artificial cerebrospinal fluid alone; NMDA = perfusion of  N -methyl-D-aspartate (1.0 mM); L-NMMA = perfusion of  N G-monomethyl-L-arginine acetate (10 mM) for 40 min; L-NMMA + NMDA = L-NMMA (10 mM) for 40 min with coperfusion of NMDA (1.0 mM) for the last 10 min. Data are presented as mean ± SD (n = 6–8). *  P < 0.01  vs. control. 

Fig. 7. Content of cyclic guanosine 3′,5′-monophosphate (cGMP) in the dorsal half of the lumbar spinal cord. Control = perfusion of artificial cerebrospinal fluid alone; NMDA = perfusion of  N -methyl-D-aspartate (1.0 mM); L-NMMA = perfusion of  N G-monomethyl-L-arginine acetate (10 mM) for 40 min; L-NMMA + NMDA = L-NMMA (10 mM) for 40 min with coperfusion of NMDA (1.0 mM) for the last 10 min. Data are presented as mean ± SD (n = 6–8). *  P < 0.01  vs. control. 

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal